Analyst Ratings For Abcam Plc (LON:ABC)
Today, Peel Hunt reiterated its Hold rating on Abcam Plc (LON:ABC) with a price target of GBX 750.
There are 1 sell rating, 5 hold ratings on the stock.
The current consensus rating on Abcam Plc (LON:ABC) is Hold (Score: 1.83) with a consensus target price of GBX 717.60 per share, a potential .
Some recent analyst ratings include
- 2/24/2017-Peel Hunt Reiterated Rating of Hold.
- 1/26/2017-Panmure Gordon Reiterated Rating of Sell.
- 1/12/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 1/10/2017-Numis Securities Ltd Reiterated Rating of Add.
- 7/25/2016-Stifel Nicolaus Reiterated Rating of Hold.
- 4/4/2016-Royal Bank Of Canada initiated coverage with a Sector Performer rating.
- 11/2/2015-Canaccord Genuity Upgrade from a “Hold” rating to a “” rating.
About Abcam Plc (LON:ABC)
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world’s 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company’s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
Recent Trading Activity for Abcam Plc (LON:ABC)
Shares of Abcam Plc closed the previous trading session at 849.00 down -5.50 -0.64% with 187,390 shares trading hands.
